CAS RN: 1416713-95-5
3-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-c]pyridine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251121
50mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1416713-95-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1416713-95-5 / 3-bromo-1-(oxan-2-yl)pyrazolo[5,4-c]pyridine
Standard CAS: 1416713-95-5
Multi CAS: No
Basic Information
copy
CAS
1416713-95-5 copy
Multi CAS
No copy
Molecular Formula
C11H12BrN3O copy
Molecular Weight
282.140000 copy
Exact Mass
281.016370 copy
SMILES
C1CCOC(C1)N2C3=C(C=CN=C3)C(=N2)Br copy
InChI
InChI=1S/C11H12BrN3O/c12-11-8-4-5-13-7-9(8)15(14-11)10-3-1-2-6-16-10/h4-5,7,10H,1-3,6H2 copy
InChIKey
FGNKYLRTNDVIHU-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.45 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
64.07 copy
TPSA
39.94 copy
LogP / Solubility
WLOGP
2.89 copy
MLOGP
2.56 copy
XLogP3
2.3 copy
Consensus LogP
2.58 copy
Log S (ESOL)
-3.76 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.96 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.02 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.39 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy